231 results on '"Geerts, William H."'
Search Results
2. Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?
3. Symptomatic Venous Thromboembolism Uncommon without Thromboprophylaxis After Isolated Lower-Limb Fracture: The Knee-to-Ankle Fracture (KAF) Cohort Study
4. Venous Thromboembolism Prophylaxis in Liver Surgery
5. The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study
6. Comparison of the Effectiveness and Safety of Low-Molecular Weight Heparin Versus Unfractionated Heparin Anticoagulation After Heart Valve Surgery
7. Guidance for Health Care Leaders During the Recovery Stage of the COVID-19 Pandemic
8. How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society
9. Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
10. Anticoagulant Use in Patients with Chronic Renal Impairment
11. Recommendations from the ICM-VTE: Trauma.
12. A PROSPECTIVE COHORT STUDY OF THE EPIDEMIOLOGY OF SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE) AFTER ISOLATED LEG FRACTURES DISTAL TO THE KNEE WFITHOUT THROMBOPROPHYLAXIS: THE KNEE-TOANKLE FRACTURE (KAF) COHORT STUDY: PAPER 032
13. CLINICALLY-IMPORTANT VENOUS THROMBOEMOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY & PREVENTION: THE D-KAF (DALTEPARIN IN KNEE-TOANKLE FRACTURE) TRIAL: PAPER 031
14. Deep venous thrombosis: clinically silent in the intensive care unit
15. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors
16. On the need for a workshop on venous thromboembolism in critical care
17. Research agenda: venous thromboembolism in medical-surgical critically ill patients
18. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma
19. Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
20. Low-Dose Heparin for Severe Sepsis
21. A prospective study of venous thromboembolism after major trauma
22. Low-Dose Heparin for Severe Sepsis
23. Strength of Evidence for Low-Molecular-Weight Heparin
24. Deep Vein Thrombosis and Its Prevention in Critically Ill Adults
25. Prevention of Venous Thromboembolism
26. Venous Thromboembolism: Risk Factors and Prophylaxis
27. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review
28. The Incidence of Symptomatic Venous Thromboembolism After Enoxaparin Prophylaxis in Lower Extremity Arthroplasty*: A Cohort Study of 1,984 Patients
29. The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin: A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty
30. Prophylaxis against Venous Thromboembolism after Major Trauma
31. The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort of 1,984 patients
32. Development and evaluation of a continuing pharmacy education (CPE) program in thrombosis management
33. Prevention of Venous Thromboembolism after Knee Arthroplasty: A Randomized, Double-Blind Trial Comparing Enoxaparin with Warfarin
34. Thromboembolism after Major Trauma
35. Current Concepts Review. Prevention of Venous Thromboembolism after Total Hip and Knee Arthroplasty.
36. Comparison of anticoagulant response to single-dose warfarin in young versus elderly subjects.: 134.
37. Differences in anticoagulant effect between prothrombin time (PT) versus factor VII concentration (FVII) when used in drug interaction studies with single-dose warfarin.: 111.
38. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism
39. Brain Natriuretic Peptide, Troponin and D-Dimer Levels in Relation to Long-Term Functional Outcome after a First Episode of Pulmonary Embolism: Results from the E.L.O.P.E. Study
40. "Post-Pulmonary Embolism Syndrome" after a First Episode of PE: Results of the E.L.O.P.E. Study
41. Dyspnea, Quality of Life and Walking Capacity during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Results of the E.L.O.P.E. Study
42. Venous Thromboembolism Prophylaxis in Liver Surgery
43. A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures
44. Is Venous Thromboprophylaxis Necessary in Patients Undergoing Minimally Invasive Surgery for a Gynecologic Malignancy?
45. Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial
46. Development and evaluation of a continuing pharmacy education (CPE) program in thrombosis management.
47. A Pilot Study of Computed Tomography–Detected Asymptomatic Pulmonary Filling Defects After Hip and Knee Arthroplasties
48. The Incidence Of Venous Thromboembolic Disease In Critically Ill Patients: A Systematic Review, Meta-Analysis And Metaregression Analysis
49. Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review
50. Vena caval filters: current knowledge, uncertainties and practical approaches
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.